Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00030966
Status:
COMPLETED
Last Update Posted:
2009-06-18
First Post:
2002-02-15
Brief Title:
Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis
Sponsor:
Biogen
Organization:
Biogen
Organization Data
Organization:
Biogen
Class:
INDUSTRY
Study ID:
C-1802
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Biogen
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Biogen Idec MD
Old Organization:
Biogen Idec
Collaborators
| Name | Class |
|---|---|
| Elan Pharmaceuticals | INDUSTRY |